A Potential Type 1 Vaccine Shows Promise

Researchers have devised a new potential type 1 diabetes vaccine that might be able to stop or slow the destruction of insulin-producing beta cells. The Swedish researcher developed a vaccine made from glutamic acid decarboxylase (GAD), a protein anchored to the surface of beta cells that many people with type 1 diabetes form antibodies against. Read more

Posted in Type I Medical Research